Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Apr;47(4):296–299. doi: 10.1136/jcp.47.4.296

Aspects of liver transplant pathology with emphasis on rejection and its mechanisms.

D G Wight 1
PMCID: PMC501929  PMID: 8027365

Full text

PDF
296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold J. C., Portmann B. C., O'Grady J. G., Naoumov N. V., Alexander G. J., Williams R. Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology. 1992 Aug;16(2):285–292. doi: 10.1002/hep.1840160202. [DOI] [PubMed] [Google Scholar]
  2. Beck S., Barrell B. G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature. 1988 Jan 21;331(6153):269–272. doi: 10.1038/331269a0. [DOI] [PubMed] [Google Scholar]
  3. Billingham M. E. Cardiac transplant atherosclerosis. Transplant Proc. 1987 Aug;19(4 Suppl 5):19–25. [PubMed] [Google Scholar]
  4. Bird G., Friend P., Donaldson P., O'Grady J., Portmann B., Calne R., Williams R. Hyperacute rejection in liver transplantation: a case report. Transplant Proc. 1989 Aug;21(4):3742–3744. [PubMed] [Google Scholar]
  5. Bismuth H., Castaing D., Ericzon B. G., Otte J. B., Rolles K., Ringe B., Sloof M. Hepatic transplantation in Europe. First Report of the European Liver Transplant Registry. Lancet. 1987 Sep 19;2(8560):674–676. doi: 10.1016/s0140-6736(87)92453-6. [DOI] [PubMed] [Google Scholar]
  6. Bäckman L., Gibbs J., Levy M., McMillan R., Holman M., Husberg B., Goldstein R., Gonwa T. A., Klintmalm G. Causes of late graft loss after liver transplantation. Transplantation. 1993 May;55(5):1078–1082. doi: 10.1097/00007890-199305000-00027. [DOI] [PubMed] [Google Scholar]
  7. Chao N. J. Graft versus host disease following allogeneic bone marrow transplantation. Curr Opin Immunol. 1992 Oct;4(5):571–576. doi: 10.1016/0952-7915(92)90028-d. [DOI] [PubMed] [Google Scholar]
  8. Colina F., Mollejo M., Moreno E., Alberti N., García I., Gómez-Sanz R., Castellano G. Effectiveness of histopathological diagnoses in dysfunction of hepatic transplantation. Review of 146 histopathological studies from 53 transplants. Arch Pathol Lab Med. 1991 Oct;115(10):998–1005. [PubMed] [Google Scholar]
  9. Colina F. The role of histopathology in hepatic transplantation. Semin Diagn Pathol. 1992 Aug;9(3):200–209. [PubMed] [Google Scholar]
  10. Davies H. S., Pollard S. G., Calne R. Y. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 1989 Mar;47(3):524–527. doi: 10.1097/00007890-198903000-00025. [DOI] [PubMed] [Google Scholar]
  11. Demetris A. J., Jaffe R., Tzakis A., Ramsey G., Todo S., Belle S., Esquivel C., Shapiro R., Markus B., Mroczek E. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol. 1988 Sep;132(3):489–502. [PMC free article] [PubMed] [Google Scholar]
  12. Demetris A. J., Jaffe R., Tzakis A., Ramsey G., Todo S., Belle S., Esquivel C., Shapiro R., Zjako A., Markus B. Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. Transplant Proc. 1989 Feb;21(1 Pt 2):2217–2220. [PMC free article] [PubMed] [Google Scholar]
  13. Demetris A. J., Nakamura K., Yagihashi A., Iwaki Y., Takaya S., Hartman G. G., Murase N., Bronsther O., Manez R., Fung J. J. A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology. 1992 Sep;16(3):671–681. doi: 10.1002/hep.1840160310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Demetris A. J., Qian S. G., Sun H., Fung J. J. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol. 1990;14 (Suppl 1):49–63. [PubMed] [Google Scholar]
  15. Donaldson P., Underhill J., Doherty D., Hayllar K., Calne R., Tan K. C., O'Grady J., Wight D., Portmann B., Williams R. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect". Hepatology. 1993 Jun;17(6):1008–1015. [PubMed] [Google Scholar]
  16. Foster P. F., Sankary H. N., Hart M., Ashmann M., Williams J. W. Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation. 1989 Jan;47(1):72–74. doi: 10.1097/00007890-198901000-00016. [DOI] [PubMed] [Google Scholar]
  17. Goldstein N. S., Hart J., Lewin K. J. Diffuse hepatocyte ballooning in liver biopsies from orthotopic liver transplant patients. Histopathology. 1991 Apr;18(4):331–338. doi: 10.1111/j.1365-2559.1991.tb00854.x. [DOI] [PubMed] [Google Scholar]
  18. Gordon R. D., Iwatsuki S., Esquivel C. O., Tzakis A., Todo S., Starzl T. E. Liver transplantation across ABO blood groups. Surgery. 1986 Aug;100(2):342–348. [PubMed] [Google Scholar]
  19. Gravanis M. B. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis. Mod Pathol. 1989 Sep;2(5):495–505. [PubMed] [Google Scholar]
  20. Gubernatis G., Kemnitz J., Bornscheuer A., Kuse E. R., Pichlmayr R. Potential various appearances of hyperacute rejection in human liver transplantation. Langenbecks Arch Chir. 1989;374(4):240–244. doi: 10.1007/BF01359560. [DOI] [PubMed] [Google Scholar]
  21. Hubscher S. G., Buckels J. A., Elias E., McMaster P., Neuberger J. Vanishing bile-duct syndrome following liver transplantation--is it reversible? Transplantation. 1991 May;51(5):1004–1010. doi: 10.1097/00007890-199105000-00014. [DOI] [PubMed] [Google Scholar]
  22. Hubscher S. G., Clements D., Elias E., McMaster P. Biopsy findings in cases of rejection of liver allograft. J Clin Pathol. 1985 Dec;38(12):1366–1373. doi: 10.1136/jcp.38.12.1366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hubscher S. G. Histological findings in liver allograft rejection--new insights into the pathogenesis of hepatocellular damage in liver allografts. Histopathology. 1991 Apr;18(4):377–383. doi: 10.1111/j.1365-2559.1991.tb00865.x. [DOI] [PubMed] [Google Scholar]
  24. Hübscher S. G., Adams D. H., Buckels J. A., McMaster P., Neuberger J., Elias E. Massive haemorrhagic necrosis of the liver after liver transplantation. J Clin Pathol. 1989 Apr;42(4):360–370. doi: 10.1136/jcp.42.4.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Judge T. Mixed chimerism after transplantation: mechanism or marker of specific tolerance? Hepatology. 1993 May;17(5):943–945. doi: 10.1002/hep.1840170527. [DOI] [PubMed] [Google Scholar]
  26. Karuppan S., Ericzon B. G., Möller E. Relevance of a positive crossmatch in liver transplantation. Transpl Int. 1991 Apr;4(1):18–25. doi: 10.1007/BF00335511. [DOI] [PubMed] [Google Scholar]
  27. Kubota K., Ericzon B. G., Reinholt F. P. Comparison of fine-needle aspiration biopsy and histology in human liver transplants. Transplantation. 1991 May;51(5):1010–1013. doi: 10.1097/00007890-199105000-00015. [DOI] [PubMed] [Google Scholar]
  28. Kubota K., Ericzon B. G., Reinholt F. P. The correlation between cytological patterns in bile and histological findings in liver transplantation. Transplantation. 1992 Apr;53(4):791–795. doi: 10.1097/00007890-199204000-00017. [DOI] [PubMed] [Google Scholar]
  29. Lautenschlager I., Höckerstedt K., Häyry P. Fine-needle aspiration biopsy in the monitoring of liver allografts. Transpl Int. 1991 Apr;4(1):54–61. doi: 10.1007/BF00335517. [DOI] [PubMed] [Google Scholar]
  30. Lautenschlager I., Höckerstedt K. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection. Transplant Proc. 1993 Feb;25(1 Pt 2):1429–1430. [PubMed] [Google Scholar]
  31. Ludwig J. Classification and terminology of hepatic allograft rejection: whither bound? Mayo Clin Proc. 1989 Jun;64(6):676–679. doi: 10.1016/s0025-6196(12)65347-6. [DOI] [PubMed] [Google Scholar]
  32. Martinez O. M., Ascher N. L., Ferrell L., Villanueva J., Lake J., Roberts J. P., Krams S. M. Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation. 1993 Apr;55(4):909–918. doi: 10.1097/00007890-199304000-00041. [DOI] [PubMed] [Google Scholar]
  33. Nakhleh R. E., Schwarzenberg S. J., Bloomer J., Payne W., Snover D. C. The pathology of liver allografts surviving longer than one year. Hepatology. 1990 Mar;11(3):465–470. doi: 10.1002/hep.1840110318. [DOI] [PubMed] [Google Scholar]
  34. Ng I. O., Burroughs A. K., Rolles K., Belli L. S., Scheuer P. J. Hepatocellular ballooning after liver transplantation: a light and electronmicroscopic study with clinicopathological correlation. Histopathology. 1991 Apr;18(4):323–330. doi: 10.1111/j.1365-2559.1991.tb00853.x. [DOI] [PubMed] [Google Scholar]
  35. Nonomura A., Kono N., Mizukami Y., Nakanuma Y. Histological changes of the liver in experimental graft-versus-host disease across minor histocompatibility barriers. VII. A light and electron microscopic study of the large bile duct. Liver. 1993 Jun;13(3):163–171. doi: 10.1111/j.1600-0676.1993.tb00625.x. [DOI] [PubMed] [Google Scholar]
  36. O'Grady J. G., Alexander G. J., Sutherland S., Donaldson P. T., Harvey F., Portmann B., Calne R. Y., Williams R. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet. 1988 Aug 6;2(8606):302–305. doi: 10.1016/s0140-6736(88)92356-2. [DOI] [PubMed] [Google Scholar]
  37. Oguma S., Belle S., Starzl T. E., Demetris A. J. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors. Hepatology. 1989 Feb;9(2):204–209. doi: 10.1002/hep.1840090207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Otte J. B. Recent developments in liver transplantation. Lessons from a 5-year experience. J Hepatol. 1991 May;12(3):386–393. doi: 10.1016/0168-8278(91)90845-3. [DOI] [PubMed] [Google Scholar]
  39. Paya C. V., Wiesner R. H., Hermans P. E., Larson-Keller J. J., Ilstrup D. M., Krom R. A., Moore S. B., Ludwig J., Smith T. F. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology. 1992 Jul;16(1):66–70. doi: 10.1002/hep.1840160113. [DOI] [PubMed] [Google Scholar]
  40. Perkins J. D., Wiesner R. H., Banks P. M., LaRusso N. F., Ludwig J., Krom R. A. Immunohistologic labeling as an indicator of liver allograft rejection. Transplantation. 1987 Jan;43(1):105–108. doi: 10.1097/00007890-198701000-00023. [DOI] [PubMed] [Google Scholar]
  41. Pfisterer M., Burkart F., Jockers G., Meyer B., Regenass S., Burckhardt D., Schmitt H. E., Müller-Brand J., Skarvan K., Stulz P. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion. Lancet. 1989 Jul 1;2(8653):1–7. doi: 10.1016/s0140-6736(89)90253-5. [DOI] [PubMed] [Google Scholar]
  42. Riely C. A., Vera S. R. Liver biopsy in the long-term follow-up of liver transplant patients: still the gold standard. Gastroenterology. 1990 Oct;99(4):1182–1183. doi: 10.1016/0016-5085(90)90644-g. [DOI] [PubMed] [Google Scholar]
  43. Roberti I., Lieberman K. V., Manzarbeitia C., Schwartz M., Reisman L., Miller C. Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection. Transplantation. 1992 Sep;54(3):471–474. doi: 10.1097/00007890-199209000-00017. [DOI] [PubMed] [Google Scholar]
  44. Rosenberg A. S., Munitz T. I., Maniero T. G., Singer A. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo. J Exp Med. 1991 Jun 1;173(6):1463–1471. doi: 10.1084/jem.173.6.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Samuel D., Gillet D., Castaing D., Reynes M., Bismuth H. Portal and arterial thrombosis in liver transplantation: a frequent event in severe rejection. Transplant Proc. 1989 Feb;21(1 Pt 2):2225–2227. [PubMed] [Google Scholar]
  46. Schlitt H. J., Nashan B., Ringe B., Bunzendahl H., Wittekind C., Wonigeit K., Pichlmayr R. Differentiation of liver graft dysfunction by transplant aspiration cytology. Transplantation. 1991 Apr;51(4):786–793. doi: 10.1097/00007890-199104000-00010. [DOI] [PubMed] [Google Scholar]
  47. Selby R., Starzl T. E., Yunis E., Brown B. I., Kendall R. S., Tzakis A. Liver transplantation for type IV glycogen storage disease. N Engl J Med. 1991 Jan 3;324(1):39–42. doi: 10.1056/NEJM199101033240107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Snover D. C., Freese D. K., Sharp H. L., Bloomer J. R., Najarian J. S., Ascher N. L. Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol. 1987 Jan;11(1):1–10. doi: 10.1097/00000478-198701000-00001. [DOI] [PubMed] [Google Scholar]
  49. Snover D. C., Sibley R. K., Freese D. K., Sharp H. L., Bloomer J. R., Najarian J. S., Ascher N. L. Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology. 1984 Nov-Dec;4(6):1212–1222. doi: 10.1002/hep.1840040620. [DOI] [PubMed] [Google Scholar]
  50. Starzl T. E., Demetris A. J., Murase N., Ildstad S., Ricordi C., Trucco M. Cell migration, chimerism, and graft acceptance. Lancet. 1992 Jun 27;339(8809):1579–1582. doi: 10.1016/0140-6736(92)91840-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Starzl T. E., Demetris A. J., Trucco M., Murase N., Ricordi C., Ildstad S., Ramos H., Todo S., Tzakis A., Fung J. J. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993 Jun;17(6):1127–1152. [PMC free article] [PubMed] [Google Scholar]
  52. Starzl T. E., Demetris A. J., Trucco M., Ramos H., Zeevi A., Rudert W. A., Kocova M., Ricordi C., Ildstad S., Murase N. Systemic chimerism in human female recipients of male livers. Lancet. 1992 Oct 10;340(8824):876–877. doi: 10.1016/0140-6736(92)93286-v. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Starzl T. E., Demetris A. J., Van Thiel D. Liver transplantation (1). N Engl J Med. 1989 Oct 12;321(15):1014–1022. doi: 10.1056/NEJM198910123211505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Starzl T. E., Demetris A. J., Van Thiel D. Liver transplantation (2). N Engl J Med. 1989 Oct 19;321(16):1092–1099. doi: 10.1056/NEJM198910193211606. [DOI] [PubMed] [Google Scholar]
  55. Steinman R. M., Inaba K., Austyn J. M. Donor-derived chimerism in recipients of organ transplants. Hepatology. 1993 Jun;17(6):1153–1156. [PubMed] [Google Scholar]
  56. Takatsu K. Interleukin-5. Curr Opin Immunol. 1992 Jun;4(3):299–306. doi: 10.1016/0952-7915(92)90080-x. [DOI] [PubMed] [Google Scholar]
  57. Takemoto S., Terasaki P. I., Cecka J. M., Cho Y. W., Gjertson D. W. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med. 1992 Sep 17;327(12):834–839. doi: 10.1056/NEJM199209173271202. [DOI] [PubMed] [Google Scholar]
  58. Tanaka M., Umihara J., Shimmoto K., Cui S. J., Sata H., Ishikawa T., Ishikawa E. The pathogenesis of graft-versus-host reaction in the intrahepatic bile duct. An immunohistochemical study. Acta Pathol Jpn. 1989 Oct;39(10):648–655. doi: 10.1111/j.1440-1827.1989.tb02412.x. [DOI] [PubMed] [Google Scholar]
  59. Wecker H., Auchincloss H., Jr Cellular mechanisms of rejection. Curr Opin Immunol. 1992 Oct;4(5):561–566. doi: 10.1016/0952-7915(92)90026-b. [DOI] [PubMed] [Google Scholar]
  60. Wee S. L., Cosimi A. B., Preffer F. I., Rothlein R., Faanes R., Conti D., Colvin R. B. Functional consequences of anti-ICAM-1 (CD54) in cynomolgus monkeys with renal allografts. Transplant Proc. 1991 Feb;23(1 Pt 1):279–280. [PubMed] [Google Scholar]
  61. Wiesner R. H., Ludwig J., Krom R. A., Hay J. E., van Hoek B. Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. Mayo Clin Proc. 1993 Jan;68(1):69–79. doi: 10.1016/s0025-6196(12)60022-6. [DOI] [PubMed] [Google Scholar]
  62. Williams J. W., Peters T. G., Vera S. R., Britt L. G., van Voorst S. J., Haggitt R. C. Biopsy-directed immunosuppression following hepatic transplantation in man. Transplantation. 1985 Jun;39(6):589–596. doi: 10.1097/00007890-198506000-00003. [DOI] [PubMed] [Google Scholar]
  63. Wright T. L. Cytomegalovirus infection and vanishing bile duct syndrome: culprit or innocent bystander? Hepatology. 1992 Aug;16(2):494–496. doi: 10.1002/hep.1840160231. [DOI] [PubMed] [Google Scholar]
  64. Yanaga K., Makowka L., Starzl T. E. Is hepatic artery thrombosis after liver transplantation really a surgical complication? Transplant Proc. 1989 Jun;21(3):3511–3513. [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES